MESA, Ariz. — April 1, 2011 — Predictive Biomarker Sciences (PBS-Bio) decodes the workings of drugs made by two private firms in abstracts presented this week at the 102nd annual conference of the American Association for Cancer Research.
The conference runs April 2-6 at the Orange County Convention Center in Orlando, Fla. The presentations will be given on April 5.
In one abstract, PBS-Bio shows how the drug UNBS1450, made by Unibioscreen, a Belgian firm, affects two genes — MCL1 and MYC.